OBJECTIVE: We aimed to describe the clinical features and outcome of human parechovirus
(HPeV) encephalitis cases identified by the Australian Childhood Encephalitis (ACE) study …

Objective To assess the role of human parechoviruses (HPeVs) as a cause of neonatal
cerebral infection and to report neuroimaging findings of newborn infants with encephalitis …

Two infants developed encephalitis in the late neonatal period due to human parechovirus
type 3 (HPeV-3). This finally resulted in intractable seizures leading to death. Both presented …

Human parechoviruses (HPeVs) cause a spectrum of disease ranging from self-limiting
illness to severe disease and, sometimes, death. We describe the clinical characteristics and …

Background: Human parechovirus particularly genotype 3 (HPeV3) is an emerging infection
affecting predominantly young infants. The potential for neurologic sequelae in a vulnerable …

Aim The human parechovirus (HPeV) is an increasingly recognised cause of sepsis and
central nervous system infection in young infants for which there are limited long‐term …

Background: Human parechoviruses (hPeV) are increasingly recognized as significant
etiological agents for meningoencephalitis especially in young children, but testing of …

Epidemics of human parechovirus (HPeV) causing disease in young children have occurred
every 2 years in Australia since 2013. HPeV genotype 3 caused the epidemic from late 2017 …

Abstract Introduction Human parechoviruses (HPeV) have been recognized as the causative
agents of central nervous system (CNS) infection of infants and young children in different …

Background: Human parechovirus (HPeV) infections of the central nervous system (CNS) in
children can be associated with severe outcomes such as neonatal sepsis-like illness …